The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 29, 2015
Filed:
Jun. 14, 2010
Jamal Tazi, Clapiers, FR;
Florence Mahuteau, Saint Remy les Chevreuses, FR;
Romain Najman, L'Hay-les-Roses, FR;
Didier Scherrer, Castelnau le Lez, FR;
Noelie Campos, Le Cres, FR;
Aude Garcel, Le Cres, FR;
Jamal Tazi, Clapiers, FR;
Florence Mahuteau, Saint Remy les Chevreuses, FR;
Romain Najman, L'Hay-les-Roses, FR;
Didier Scherrer, Castelnau le Lez, FR;
Noelie Campos, Le Cres, FR;
Aude Garcel, Le Cres, FR;
ABIVAX, Paris, FR;
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris, FR;
INSTITUT CURIE, Paris, FR;
UNIVERSITE DE MONTPELLIER 2, Montpellier, FR;
Abstract
The present invention relates to compound Formula (I) wherein: Formula (II) means a pyridazine, a pyrimidine or a pyrazine group, R independently represent a hydrogen atom, a halogen atom or a group chosen among a CN group, a hydroxyl group, a COORgroup, a (C-C)fluoroalkyl group, a (C-C)fluoroalkoxy group, a NOgroup, a NRRgroup, a (C-C)alkoxy group, a phenoxy group and a (C-C)alkyl group, said alkyl being optionally mono-substituted by a hydroxyl group, n is 1, 2 or 3, n is 1 or 2, R is a hydrogen atom, a halogen atom or a group chosen among a (C-C)alkyl group, a hydroxyl group, a COORgroup, a NOgroup, a NRRgroup, a morpholinyl or a morpholino group, a N-methylpiperazinyl group, a (C-C)fluoroalkyl group, a (C-C)alkoxy group and a CN group, Z is N or C, Y is N or C, X is N or C, W is N or C, T is N or C, U is N or C, for use as an agent for preventing, inhibiting or treating AIDS. Some of said compounds are new and also form part of the invention.